Download the whitepaper to gain insights that can help inform your manufacturing approach.
Drug pipelines are evolving rapidly, with increasing focus on highly potent APIs, targeted therapies, and complex oral solid dose (OSD) formulations. As development complexity grows, manufacturing strategy has become a critical factor in bringing new medicines to market efficiently.
In this whitepaper, “Placing drug strategies on a solid foundation for success,” explore the industry trends influencing pharmaceutical outsourcing and commercial manufacturing decisions today.
Download the whitepaper to discover:
- Key trends shaping pharmaceutical manufacturing and outsourcing strategies
- Why complex compounds and highly potent APIs are influencing commercial manufacturing decisions
- Considerations for scaling oral solid dose products from development to commercial supply
- What drug developers should evaluate when selecting a contract manufacturing organization
Powered by Pfizer expertise, Pfizer CentreOne provides commercial manufacturing capabilities designed to help pharmaceutical companies navigate complex OSD requirements and support their drug commercialization strategies.
